Global Kidney Health Atlas (GKHA): design and methods.

[1]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[2]  Alexander C Wagenaar,et al.  Using routine health information systems for well-designed health evaluations in low- and middle-income countries. , 2016, Health policy and planning.

[3]  Mark D. Huffman,et al.  World Heart Federation Emerging Leaders Program: An Innovative Capacity Building Program to Facilitate the 25 × 25 Goal. , 2015, Global heart.

[4]  R. Singhal,et al.  Prevalence Of Chronic Kidney Disease In India: A Systematic Review And Meta-Analysis Of Observational Studies. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  Gunn Marit Aasvang,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[6]  M. Hadfield,et al.  Qualitative research in healthcare: An introduction to grounded theory using thematic analysis , 2015, The journal of the Royal College of Physicians of Edinburgh.

[7]  A. Abu-Hanna,et al.  Translational research in nephrology: chronic kidney disease prevention and public health , 2015, Clinical kidney journal.

[8]  Bernadette A. Thomas,et al.  Maintenance Dialysis throughout the World in Years 1990 and 2010. , 2015, Journal of the American Society of Nephrology : JASN.

[9]  Raymond Vanholder,et al.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology , 2015, The Lancet.

[10]  A. Kengne,et al.  Diabetic nephropathy in Africa: A systematic review. , 2015, World journal of diabetes.

[11]  A. Garg,et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.

[12]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[13]  S. Naicker,et al.  The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[14]  P. Vineis,et al.  The road to 25×25: how can the five-target strategy reach its goal? , 2014, The Lancet. Global health.

[15]  G. Mensah,et al.  1990-2010 global cardiovascular disease atlas. , 2014, Global heart.

[16]  U. Linnenkamp,et al.  The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. , 2014, Diabetes research and clinical practice.

[17]  A. Levin,et al.  Canadian chronic kidney disease clinics: a national survey of structure, function and models of care , 2014, Canadian journal of kidney health and disease.

[18]  M. McCarthy.  Reducing inequality is crucial to implementing universal health coverage, says WHO report , 2013, BMJ : British Medical Journal.

[19]  J. Craig,et al.  Prevention, detection and management of early chronic kidney disease: A systematic review of clinical practice guidelines , 2013, Nephrology.

[20]  Desmond E. Williams,et al.  Medical costs of CKD in the Medicare population. , 2013, Journal of the American Society of Nephrology : JASN.

[21]  A. Levin,et al.  Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. , 2013, Kidney international.

[22]  David W. Johnson,et al.  KHA‐CARI Guideline: Early chronic kidney disease: Detection, prevention and management , 2013, Nephrology.

[23]  T. Groves.  Development of health systems and universal coverage should be evidence based, says WHO , 2012, BMJ : British Medical Journal.

[24]  Chirag R Parikh,et al.  Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. , 2012, Kidney international.

[25]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[26]  G. Remuzzi,et al.  The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. , 2011, Kidney international.

[27]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[28]  David Whiting,et al.  The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. , 2011, Diabetes research and clinical practice.

[29]  L. Newman.  Telephone survey methods: implications of the increasing mobile‐only population for public health research , 2011, Australian and New Zealand journal of public health.

[30]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[31]  Jason M Etchegaray,et al.  Understanding Evidence-Based Research Methods: Reliability and Validity Considerations in Survey Research , 2010, HERD.

[32]  H. Trivedi.  Cost implications of caring for chronic kidney disease: are interventions cost-effective? , 2010, Advances in chronic kidney disease.

[33]  Marcello Tonelli,et al.  Early recognition and prevention of chronic kidney disease , 2010, The Lancet.

[34]  A. Krishnan,et al.  Capacity to control noncommunicable diseases in the countries of South-East Asia. , 2009, Health policy.

[35]  S. Rattanasiri,et al.  Prevalence of chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical nephrology.

[36]  Keith C. Norris,et al.  Chronic kidney disease in the United States: a public policy imperative. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[37]  R. Scherpbier,et al.  Assessment of the health system and policy environment as a critical complement to tracking intervention coverage for maternal, newborn, and child health , 2008, The Lancet.

[38]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[39]  A. Bello,et al.  Chronic kidney disease: the global challenge , 2005, The Lancet.

[40]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[41]  R. Kravitz,et al.  Methods in survey research: evidence for the reliability of group administration vs personal interviews. , 2001, American journal of public health.

[42]  J. Eaden,et al.  Questionnaires: the use and abuse of social survey methods in medical research , 1999, Postgraduate medical journal.

[43]  J. Calder.  Survey research methods , 1998, Medical education.

[44]  A. Levin,et al.  Effective CKD care in European countries: challenges and opportunities for health policy. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  The Lancet Diabetes & Endocrinology.  Monitoring progress in NCDs: key to accountability. , 2015, The lancet. Diabetes & endocrinology.

[46]  J. Feehally.  Chronic kidney disease: Health burden of kidney disease recognized by UN , 2012, Nature Reviews Nephrology.

[47]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[48]  Edinburgh Research Explorer Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2022 .